U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.145G>A (p.Asp49Asn) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 12, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004998339.1

Allele description [Variation Report for NM_000546.6(TP53):c.145G>A (p.Asp49Asn)]

NM_000546.6(TP53):c.145G>A (p.Asp49Asn)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.145G>A (p.Asp49Asn)
HGVS:
  • NC_000017.11:g.7676224C>T
  • NG_017013.2:g.16327G>A
  • NM_000546.6:c.145G>AMANE SELECT
  • NM_001126112.3:c.145G>A
  • NM_001126113.3:c.145G>A
  • NM_001126114.3:c.145G>A
  • NM_001126118.2:c.28G>A
  • NM_001276695.3:c.28G>A
  • NM_001276696.3:c.28G>A
  • NM_001276760.3:c.28G>A
  • NM_001276761.3:c.28G>A
  • NP_000537.3:p.Asp49Asn
  • NP_000537.3:p.Asp49Asn
  • NP_001119584.1:p.Asp49Asn
  • NP_001119585.1:p.Asp49Asn
  • NP_001119586.1:p.Asp49Asn
  • NP_001119590.1:p.Asp10Asn
  • NP_001263624.1:p.Asp10Asn
  • NP_001263625.1:p.Asp10Asn
  • NP_001263689.1:p.Asp10Asn
  • NP_001263690.1:p.Asp10Asn
  • LRG_321t1:c.145G>A
  • LRG_321:g.16327G>A
  • LRG_321p1:p.Asp49Asn
  • NC_000017.10:g.7579542C>T
  • NM_000546.4:c.145G>A
  • NM_000546.5(TP53):c.145G>A
  • NM_000546.5:c.145G>A
  • P04637:p.Asp49Asn
  • p.D49N
Protein change:
D10N
Links:
UniProtKB: P04637#VAR_044572; dbSNP: rs587780728
NCBI 1000 Genomes Browser:
rs587780728
Molecular consequence:
  • NM_000546.6:c.145G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.145G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.145G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.145G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005625950Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Uncertain significance
(Apr 12, 2024)
unknownclinical testing

PubMed (15)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions.

Su Y, Yao Q, Xu Y, Yu C, Zhang J, Wang Q, Li J, Shi D, Yu B, Zeng Y, Zhu X, Bai Q, Zhou X.

Front Genet. 2021;12:674094. doi: 10.3389/fgene.2021.674094.

PubMed [citation]
PMID:
34917121
PMCID:
PMC8670232

Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.

Fortuno C, Lee K, Olivier M, Pesaran T, Mai PL, de Andrade KC, Attardi LD, Crowley S, Evans DG, Feng BJ, Foreman AKM, Frone MN, Huether R, James PA, McGoldrick K, Mester J, Seifert BA, Slavin TP, Witkowski L, Zhang L, Plon SE, Spurdle AB, et al.

Hum Mutat. 2021 Mar;42(3):223-236. doi: 10.1002/humu.24152. Epub 2020 Dec 25.

PubMed [citation]
PMID:
33300245
PMCID:
PMC8374922
See all PubMed Citations (15)

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV005625950.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (15)

Description

The TP53 c.145G>A (p.Asp49Asn) variant has been reported in the published literature in individuals with different types of cancer including mesothelioma and skin cancer (PMID: 26554828 (2016)), chronic lymphocytic leukemia (PMID: 23525797 (2013)), pediatric brain tumors (PMDI: 22797305 (2012)), and breast cancer (PMID: 34917121 (2021)). Experimental studies have indicated that this variant retains TP53 function (PMIDs: 12826609 (2013), 30224644 (2018), and 34793697 (2021)). The frequency of this variant in the general population, 0.000008 (2/251366 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 25, 2025